AzTrials
AzTrials

Abdominal Pain (AP)EMERGE-AbdomenNCT07815795

Emergency Medicine Evaluation for Acute Abdominal Pain - a Pragmatic Randomized Trial

A study testing Emergency Medicine Initial Assessment and Standard Surgical Assessment in people with Abdominal Pain (AP) and Acute Abdomen, run by Haukeland University Hospital at 1 site in Norway.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn whether initial assessment by a physician specializing in emergency medicine can improve the care of adults who come to the emergency department with acute abdominal pain or another undifferentiated acute abdominal condition and are referred for surgical assessment. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Emergency Medicine Initial Assessment and Standard Surgical Assessment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
440 participants
Where
1 siteNorway
Study dates
15 Sep 2026to 1 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • • Age ≥18 years
  • Referred to or arrived at the emergency department at Haukeland University Hospital and referred for gastrointestinal surgical assessment on arrival
  • Presenting with undifferentiated acute abdominal pain or another acute abdominal problem for which the final diagnosis and level of treatment have not been clarified on arrival
  • Has capacity to consent and provides informed consent If a patient is initially referred to another specialty but, after primary triage/initial assessment, is reclassified as having a gastrointestinal surgical problem before the first physician contact, the patient may be included if the other criteria are fulfilled.

Who cannot join

  • • Age <18 years
  • Does not have capacity to consent
  • Previously included in the study
  • Known and clarified surgical diagnosis with an established treatment plan on arrival
  • Open return access to the gastrointestinal surgery department (for example, known malignancy)
  • Admission for a clearly defined postoperative complication following recent surgery

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dagfinn L Markussen, MD, PhD contact

55 97 50 00 ext. +47

dafi@ihelse.net

Hilde Halland, MD, PhD contact

55 97 50 00 ext. +47

Norway1 site
  • Haukeland University Hospital

    Bergen, Vestland, 5020

    Dagfinn L Markussen, MD, PhD, 55 97 50 00 ext. +47, dafi@ihelse.net

    Hilde Halland, MD, PhD, 55 97 50 00 ext. +47

Other trials in Norway

About this study

Official title: Emergency Medicine-Led Initial Evaluation for Patients With Acute Abdominal Pain: A Pragmatic Individual Randomized Controlled Trial

The goal of this clinical trial is to learn whether initial assessment by a physician specializing in emergency medicine can improve the care of adults who come to the emergency department with acute abdominal pain or another undifferentiated acute abdominal condition and are referred for surgical assessment.

The main questions it aims to answer are:

Read more

Does initial assessment by an emergency medicine physician reduce the time patients spend in the emergency department? Is this model of care as safe as standard surgical assessment, including the risk of readmission and death within 30 days?

Researchers will compare patients who receive their initial assessment from an experienced emergency medicine physician with patients who receive standard care, where the initial assessment is usually performed by a junior surgical physician.

Participants will:

Be randomly assigned to one of the two models of initial assessment Receive diagnostic tests and treatment according to usual clinical practice Be followed for outcomes such as use of diagnostic imaging, treatment, hospital stay, readmission, and mortality Be asked to complete a short questionnaire about their experience in the emergency department

The study does not involve experimental drugs, devices, or procedures. The intervention changes which type of physician is responsible for the initial assessment and management in the emergency department.

Read the detailed description

This is a single-center, pragmatic, individually randomized, open-label, controlled clinical trial conducted in the emergency department at Haukeland University Hospital, Bergen, Norway. The study evaluates an alternative model for the initial assessment and management of adult patients presenting with undifferentiated acute abdominal conditions who are referred for gastrointestinal surgical assessment.

In current practice, these patients are usually initially assessed by a junior physician working in the surgical service. Diagnostic evaluation and treatment are subsequently discussed with more experienced surgical physicians as needed. This model may require several sequential assessments and may contribute to prolonged emergency department length of stay.

Emergency medicine was established as a medical specialty in Norway in 2019. Physicians specializing in emergency medicine are trained to assess a broad range of undifferentiated acute conditions, initiate diagnostic investigations and treatment, determine the appropriate level of care, and coordinate involvement of other specialties. However, there is limited evidence from Norwegian emergency departments regarding how the use of experienced emergency medicine physicians for the initial management of patients traditionally referred directly to surgical specialties affects patient flow, resource use, and safety.

The study therefore compares two models of initial care. In the intervention group, an experienced physician from the Department of Emergency Medicine, either a senior resident or consultant in emergency medicine, has primary responsibility for the initial assessment and management of the patient in the emergency department. This includes clinical assessment, selection and prioritization of laboratory and imaging investigations, initiation of treatment, and decisions regarding further disposition. Gastrointestinal surgeons or other relevant specialists are involved whenever clinically indicated.

In the control group, patients receive usual care according to the existing surgical admission pathway. The first medical assessment is usually performed by a junior physician working in the surgical service, with involvement of more experienced surgical physicians according to standard clinical routines.

The intervention does not introduce experimental diagnostic tests, medications, devices, or invasive procedures. Diagnostic investigations and treatment in both groups are performed according to usual clinical practice and applicable local and national guidelines. The difference between the study groups is primarily which physician group has responsibility for the initial assessment and coordination of care.

Participants are randomized in a 1:1 ratio using an electronic randomization system. Variable block sizes are used to maintain balance while limiting predictability of allocation. Because of the nature of the intervention, treating physicians and participants cannot be blinded to treatment allocation. Key study data are obtained from routinely collected electronic health record information where possible. Assessment of diagnostic agreement is planned to be performed by reviewers who are blinded to treatment allocation.

The primary analysis will follow the intention-to-treat principle. Participants will therefore be analyzed according to their assigned group regardless of subsequent changes in clinical responsibility or whether the final diagnosis is gastrointestinal surgical. Crossovers between the two models of care will be recorded, and a per-protocol analysis is planned as a sensitivity analysis.

The study is designed as a pragmatic evaluation of a change in the organization of emergency care. It is intended to determine whether assigning experienced emergency medicine physicians to the initial management of this patient population can improve emergency department efficiency while maintaining patient safety and appropriate use of diagnostic and therapeutic resources.

Because the intervention concerns organization of routine clinical care rather than an experimental treatment, the study is considered to involve low additional risk. Safety is monitored throughout the study. An independent Data Monitoring Committee reviews predefined safety information and may recommend continuation of the study, modification of study procedures or safety measures, temporary suspension of recruitment, or termination of the study if clinically important safety concerns arise. A planned interim safety review will be conducted after approximately 200 participants have been enrolled. Serious unexpected patient harm that may be related to the model of care will be reviewed independently irrespective of the timing of the planned safety review.

Being tested
Emergency Medicine Initial Assessment, Standard Surgical Assessment
Keywords
Emergency Medicine, Emergency Department, Acute Abdominal Pain, Patient Flow, Length of Stay, Pragmatic Randomized Trial, Health Services Research
Medical subject headings
Abdominal Pain, Abdomen, Acute, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Emergency Medicine Initial AssessmentOther

    Initial assessment and management in the emergency department by an experienced emergency medicine physician (senior resident or consultant in emergency medicine), including clinical assessment, selection and prioritization of diagnostic investigations, initiation of treatment, and decisions regarding further disposition. Surgical or other specialist input is obtained when clinically indicated.

  • Standard Surgical AssessmentOther

    Standard care according to the existing surgical admission pathway. The initial medical assessment will usually be performed by a junior physician working in the surgical service, with diagnostic evaluation and treatment conducted according to usual clinical practice. More experienced surgical physicians will be involved according to standard routines and clinical need.

Study groups in NCT07815795
Study groupRoleWhat they receive
Emergency Medicine Initial AssessmentExperimentalParticipants randomized to this arm will receive their initial assessment and management in the emergency department from an experienced emergency medicine physician (senior resident or consultant in emergency medicine). The emergency medicine physician will have primary responsibility for the initial clinical assessment, diagnostic work-up, initiation of treatment, and decisions regarding further disposition. Gastrointestinal surgeons or other relevant specialists will be involved when clinically indicated.
Receives: Other: Emergency Medicine Initial Assessment
Standard Surgical AssessmentActive comparatorParticipants randomized to this arm will receive standard care according to the existing surgical admission pathway. The initial medical assessment will usually be performed by a junior physician working in the surgical service, with diagnostic evaluation and treatment conducted according to usual clinical practice. More experienced surgical physicians will be involved according to standard routines and clinical need.
Receives: Other: Standard Surgical Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Emergency Department Length of Stay

    Emergency department length of stay, measured in minutes from the participant's registered arrival at the emergency department to registered departure from the emergency department. Departure is defined as transfer to an inpatient ward, operating room, or another department, or discharge directly from the emergency department. For participants who die in the emergency department, the time of death will be used as the departure time. Times will be obtained from electronic timestamps in the hospital electronic health record.

    Measured: From registered arrival at the emergency department until departure from the emergency department, assessed up to 48 hours.

Secondary outcomes (21)
  1. Tentative Diagnosis Documented

    Proportion of participants with a tentative diagnosis documented in the admission note.

    Measured: Within 48 hours of emergency department arrival.

  2. Diagnostic Agreement

    Agreement between the tentative diagnosis documented and validated in the admission note within 48 hours of emergency department arrival and the final principal discharge diagnosis from the index hospitalization.

    Measured: From emergency department arrival until discharge from the index hospitalization, assessed up to 30 days after arrival.

  3. Use of Computed Tomography

    Proportion of participants undergoing computed tomography during the first hospital day.

    Measured: Within the first 24 hours of the index hospitalization

  4. Use of Ultrasound

    Proportion of participants undergoing ultrasound performed by the radiology department during the first hospital day.

    Measured: Within the first 24 hours of the index hospitalization

  5. Assessment by a More Experienced Surgical Physician

    Proportion of participants assessed in the emergency department by a senior surgical resident or surgical consultant in addition to the initial assessing physician as documented in the physisians note.

    Measured: From emergency department arrival until departure from the emergency department, assessed up to 48 hours after arrival.

  6. Antibiotic Treatment

    Proportion of participants receiving systemic antibiotic treatment during the index hospitalization.

    Measured: From emergency department arrival until discharge from the index hospitalization, assessed up to 30 days after arrival.

  7. Antibiotic Treatment Concordant With National Guidelines

    Among participants receiving antibiotics, the proportion receiving an antimicrobial agent consistent with applicable national treatment guidelines. Assessment concerns choice of antimicrobial agent and does not include dose.

    Measured: From emergency department arrival until discharge from the index hospitalization, assessed up to 30 days after arrival.

  8. Invasive Abdominal Intervention

    Proportion of participants undergoing at least one therapeutic invasive abdominal intervention, including surgery, image-guided intervention, or therapeutic endoscopic intervention such as ERCP related to the acute condition.

    Measured: From emergency department arrival through 30 days after arrival.

  9. Admission to a Gastrointestinal Surgical Ward

    Proportion of participants admitted from the emergency department to a gastrointestinal surgical inpatient ward.

    Measured: From emergency department arrival until departure from the emergency department, assessed up to 48 hours after arrival.

  10. Non-Gastrointestinal Surgical Condition Admitted to a Gastrointestinal Surgical Ward

    Proportion of participants dispositioned from the emergency department to a gastrointestinal surgical inpatient ward who have a final principal diagnosis outside the gastrointestinal surgical specialty, receive predominantly non-surgical treatment, and do not undergo surgery during the index hospitalization.

    Measured: From emergency department arrival until discharge from the index hospitalization, assessed up to 30 days after arrival.

  11. 30-Day Readmission

    Proportion of participants with at least one unplanned acute hospital readmission within 30 days after discharge from the index hospitalization.

    Measured: Within 30 days after discharge from the index hospitalization

  12. 30-Day All-Cause Mortality

    Proportion of participants who die from any cause within 30 days after Emergency Department presentation.

    Measured: Within 30 days after ED presentation

  13. Time From Emergency Department Arrival to Completion of Initial Medical Assessment

    Time in minutes from registered arrival at the emergency department until the treating physician is registered as having completed the initial assessment in the electronic emergency department system.

    Measured: From emergency department arrival until completion of the initial medical assessment, assessed up to 48 hours after arrival.

  14. Time to First Antibiotic Dose

    Among participants receiving antibiotics in the emergency department, time in minutes from emergency department arrival to actual administration of the first antibiotic dose.

    Measured: From emergency department arrival until departure from the emergency department, assessed up to 48 hours after arrival.

  15. Duration of Antibiotic Treatment

    Total duration of antibiotic treatment, including planned treatment continuing after hospital discharge.

    Measured: From initiation of antibiotic treatment until completion of the treatment course, assessed up to 30 days after emergency department arrival.

  16. Time to First Relevant Diagnostic Imaging

    Time in minutes from emergency department arrival to completion of the first relevant computed tomography or ultrasound examination.

    Measured: From emergency department arrival until completion of the first relevant diagnostic imaging examination during the index hospitalization, assessed up to 30 days after arrival.

  17. Time to Surgery

    Among participants undergoing surgery for the acute abdominal condition during the index hospitalization, time in minutes from registered emergency department arrival to start of anesthesia.

    Measured: From emergency department arrival until start of anesthesia for surgery during the index hospitalization, assessed up to 30 days after arrival.

  18. Time to Invasive Intervention

    For patients that undergo an invasive intervention: Time in minutes from emergency department arrival to the start of the first relevant invasive intervention, including surgery, ERCP, or percutaneous image-guided intervention.

    Measured: From emergency department arrival until start of the first relevant invasive intervention during the index hospitalization, assessed up to 30 days after arrival.

  19. Total Hospital Length of Stay

    Duration of the index hospitalization, measured from emergency department arrival to hospital discharge.

    Measured: From emergency department arrival until discharge from the index hospitalization, assessed up to 90 days after arrival.

  20. Overall Patient Satisfaction

    Overall satisfaction with emergency department care measured using a single 1-to-5 Likert-scale question, with higher scores indicating greater satisfaction.

    Measured: Assessed at emergency department departure or within 48 hours after departure.

  21. Days in Hospital Within 30 Days After Emergency Department Presentation

    Cumulative number of days spent in hospital during the 30 days following the index emergency department presentation, including the index hospitalization and any unplanned revisits or readmissions resulting in hospital admission.

    Measured: From the index emergency department presentation through 30 days after presentation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2026
  2. Study start15 Sep 2026 (estimated)
  3. Primary completion14 Feb 2027 (estimated)
  4. Study completion1 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are individually randomized in a 1:1 ratio to one of two parallel care pathways: initial assessment and management by an experienced emergency medicine physician, or standard surgical assessment according to usual care. Participants remain in their assigned group for the primary intention-to-treat analysis regardless of subsequent crossover or final diagnosis.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
440 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07815795
Sponsor's protocol ID
983088
Acronym
EMERGE-Abdomen
Status last verified
Jun 2026
First submitted
2 Sep 2026
Last updated
11 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made publicly available because the study uses sensitive health information collected from electronic health records, and data sharing is subject to Norwegian data protection regulations, ethics approval, participant consent, and institutional data governance requirements.

Publications

  • Jenkins D, Thomas SA, Pathan SA, Thomas SH. Increasing consultant-level staffing as a proportion of overall physician coverage improves emergency department length of stay targets. BMC Emerg Med. 2021 Jan 13;21(1):5. doi: 10.1186/s12873-020-00399-8.

    PubMed 33441082
  • Burgess L, Ray-Barruel G, Kynoch K. Association between emergency department length of stay and patient outcomes: A systematic review. Res Nurs Health. 2022 Feb;45(1):59-93. doi: 10.1002/nur.22201. Epub 2021 Dec 21.

    PubMed 34932834
  • Jones PG, Mountain D, Forero R. Review article: Emergency department crowding measures associations with quality of care: A systematic review. Emerg Med Australas. 2021 Aug;33(4):592-600. doi: 10.1111/1742-6723.13743. Epub 2021 Mar 16.

    PubMed 33724707

Questions about this trial

What is this clinical trial studying?

A study testing Emergency Medicine Initial Assessment and Standard Surgical Assessment in people with Abdominal Pain (AP) and Acute Abdomen, run by Haukeland University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dagfinn L Markussen, MD, PhD (55 97 50 00 ext. +47, dafi@ihelse.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Emergency Department Length of Stay (time frame: From registered arrival at the emergency department until departure from the emergency department, assessed up to 48 hours.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07815795, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in